In part one of a two-part series, Dr. Justin Abbatemarco and Dr. Nicolás Lundahl Ciano-Petersen break down Merkel cell carcinoma and discuss what all neurologists need to know about it. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200260
Dr. Tesha Monteith and Dr. Ashish D. Patel discuss headache referrals and the implementation of a design thinking approach to improve access to headache care. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200336
In this lab minute, Dr. Stacey Clardy talks about paraneoplastic panels.
Dr. Stacey Clardy discusses when to test for myasthenia gravis in this lab minute.
Dr. Stacey Clardy discusses the fundamentals of the immune response to infection and explains how to accurately distinguish between past and current or recent infections.
Dr. Neha Dangayach and Drs. Yelena Bodien and Brian Edlow discuss the concept of cognitive motor dissociation (CMD) in neurocritical care, highlighting its implications for patient assessment and treatment. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200390
In the final episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss major takeaways from the new guidelines for the primary prevention of stroke. Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119
In the fourth episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss stroke prevention in pregnancy. Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119
Dr. Andy Southerland and Dr. Scott Friedenberg discuss the significant challenge of financial health within a department or practice, and how it impacts patient and provider satisfaction as well as clinical habits. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200314
In the third episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss the dietary recommendations outlined in the guidelines for primary stroke prevention. Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119
Dr. Shuvro Roy and Dr. Marisa Patryce McGinley discuss outpatient telemedicine utilization for neurologic conditions and identify potential disparities. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200407
In the second episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss the recommendations for patients with high-risk antiphospholipid profile and the increased risk of stroke. Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119
In the first episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss notable changes in the guidelines compared to previous versions, including the introduction of endometriosis as an inflammatory condition that has been shown to increase the risk of stroke. Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119
In part two of this two-part series, Dr. Jeff Ratliff and Drs. Rachel Gottlieb-Smith and Kathryn Xixis discuss the potential dangers or pitfalls of using AI to help review residency applications. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200150
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Ron Postuma discuss how clinicians should approach serological antibody testing in patients with REM behavior disorder or other associated neurologic symptoms. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200311
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Ron Postuma discuss how frequently the IGLON5 antibody is identified among patients with idiopathic REM behavior disorder. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200311
In part one of this two-part series, Dr. Jeff Ratliff and Drs. Rachel Gottlieb-Smith and Kathryn Xixis discuss the potential advantages that the increasing accessibility of artificial intelligence presents for the identification and recruitment of the next generation of neurologists. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200150
In the third part of this three-part series, Dr. Irfan Sheikh and Dr. Roohi Katyal discuss the best strategies to enhance EEG education in child neurology and neurodevelopmental disability programs. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200112
In the second part of this three-part series, Dr. Irfan Sheikh and Dr. Roohi Katyal discuss the current state of EEG education in child neurology and neurodevelopmental disability programs, focusing on EEG rotation characteristics and resident evaluations. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200112
In the first part of this three-part series, Dr. Irfan Sheikh and Dr. Roohi Katyal discuss the significance of this publication and the objectives their team aimed to achieve with the study. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200112
Dr. Derek Stitt and Dr. Reece Hass discuss the neuroanatomy of the cough reflex, the relationship between cough and pain, and specific neurological conditions that can lead to neurogenic cough. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000210064
In the second part of this two-part series, Dr. Justin Abbatemarco and Drs. Claire J. Creutzfeldt and Robert G. Holloway discuss how medical forecasting can assist in answering questions that patients or family members often ask. Show reference: https://jamanetwork.com/journals/jamaneurology/article-abstract/2820194
In part one of this two-part series, Dr. Justin Abbatemarco and Drs. Claire J. Creutzfeldt and Robert G. Holloway discuss understanding medical forecasting. Show reference: https://jamanetwork.com/journals/jamaneurology/article-abstract/2820194
In this episode of Neurology Minute, Dr. Stacey Clardy discusses Amyloidosis. Show reference: https://doi.org/10.1111/imj.15974
In the second part of this two-part series, Dr. Stacey Clardy and Dr. Bhooma R. Aravamuthan talk about the future of the diagnostic label for cerebral palsy. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200353
Dr. Vikram Karnik and Dr. Kate Wyman-Chick discuss distinguishing prodromal dementia with Lewy bodies from prodromal Alzheimer disease and the implications for clinical practice. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200380
In the first part of this two-part series, Dr. Stacey Clardy and Dr. Bhooma R. Aravamuthan discuss the current definition of cerebral palsy and the appropriate diagnostic labeling in clinical practice. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200353
In part three of this three-part series, Dr. Jason Crowell and Max Goldman discuss potential legislative actions affecting the 2025 Medicare Physician Fee Schedule. Show references: Fee for Service Page Webinar sign up link Full Physician Fee Schedule Final Rule...
In part two of this three-part series, Dr. Jason Crowell and Matt Kerschner explores advancements and challenges in telehealth services for 2025. Show references: Fee for Service Page Webinar sign up link Full Physician Fee Schedule Final Rule...
In part one of this three-part series, Dr. Jason Crowell and Matt Kerschner discuss the key updates and changes to the Medicare Physician Fee Schedule for 2025. Show references: Fee for Service Page Webinar sign up link Full Physician Fee Schedule Final Rule...
